维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="MEKHAIL T"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	PhaseⅠ/Ⅱtrial of subcutaneous interleukin-2,granulocyte-macrophage colony-stimulating factor and interferon-αin patients with metastatic renal cell carcinoma显示文摘	Garcia JA Mekhail T Elson P	2012	BJU Int2012，109，1：	1
2	Paclitaxel in cancer therapy 显示文摘	MEKHAIL T M MARKMAN M	2002	Expert Opin Pharmacother2002，3，6：	1
3	Enteral nutrition during the treatment of head and neck carcinoma 显示文摘	Mekhail T M Adelstein D J Rybicki L A	2001	Cancer2001，91，9：	1
4	Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases:results of the EORTC 22952-26001 study显示文摘	Mekhail T Sombeck M Sollaccio R	2011	Curr Oncol Rep2011，13，4：	1
5	A phaseⅡtrial of low doseinterleukin-2(IL-2)and bevaeizumab for patients(pts)with meta-static renal cell carcinoma(mRCC)显示文摘	Tamaskar IB Rini B Mekhail T	2007	J Clin Oncol2007，25，18：	1
6	Phase I trial of PEGinterferon and recombinant IL-2 in patients with metastatic renal cell carcinoma显示文摘	George S Hutson TE Mekhail T	2008	Cancer Chemother Pharmacol2008，62，2：	1
7	Phase Ⅱ trial of becatecarin (rebeccamycin analogue ) in relapsed sensitive small cell lung cancer (SCLC)显示文摘	Dowlati A Mekhail T O'Brien T	2008	J Clin Oncol2008，26，19：	1
8	Interleukin-2 in cancer therapy: uses and optimum management of adverse effects显示文摘	Mekhail T Wood L Bukowski R	2000	Bio Drugs2000，14，5：	1
9	Thymic neoplasms:a clinical update显示文摘	Mikhail M Mekhail Y Mekhail T		0，，：	1
10	Is lung cancer in the non-smoker a different disease显示文摘	Mekhail T Arroliga AC	2004	Chest2004，126，2：	1
11	Phase I/II trial of subcutane- ous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-ct in patients with metastatic renal cell carcinoma 显示文摘	Garcia JA Mekhail T Elson P	2012	BJU Int2012，109，1：	1
12	Amrubicin and carboplatin with pegfilgrastim in patients with extensive-stage small-cell lung cancer(ES-SCLC):a phase Ⅱstudy of the Sarah Cannon Research Institute(SCRI)显示文摘	Shipley D Hainsworth JD Mekhail T		0，，：	1
13	Interleukin-2 in canc-er therapy : uses and optimum management of adverse effects显示文摘	MEKHAIL T’WOOD L’BUKOWSKI R	2000	Bio Drugs2000，14，5：	1
14	Phase II trial of becatecarin (rebeccamycin analogue) in relapsed sensitive small cell lung cancer (SCLC) 显示文摘	Dowlati A Mekhail T O'Brien T	2008	J Clin Oncol2008，26，19：	1
15	Phase- 1I trial of re- beceamyein analog, a dual topoisomerase-I and -U inhibitor, in relapsed 'sensitive' small cell lung cancer显示文摘	Schwandt A Mekhail T Halmos B	2012	J Thorac On- col2012，7，4：	1
16	Metabo- lism, excretion and pharmacokinetics of oral Brivanib in patients with advanced or metastatic sol- id tumors 显示文摘	Mekhail T Masson E Fischer BS	2010	Drug Metab Dispo2010，38，11：	1
17	Anatomic considerations for a modified posterior approach to the scapula 显示文摘	Ebraheim N A Mekhail A O Padanilum T G	1997	Clin Orthop Relat Res1997，，334：	1
18	Enteral nutrition during the treatment of head and neck carcinoma显示文摘	Mekhail T M Adetstein D J Rybicki L A	2001	Cancer2001，91，9：	1
19	Adjuvant w- hole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: results of the EORTC 22952-26001 study显示文摘	MEKHAIL T SOMBECK M SOLLACCIO R	2011	Curt Oncol Rep2011，13，4：	1
20	Paclitaxel in cancer therapy显示文摘	MEKHAIL T M MARKMAN M	2002	Expert Opinion on Pharmacotherapy2002，3，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示